Stock Markets March 30, 2026

Wolfe Research Lifts CrowdStrike to Outperform Citing Anthropic AI as Spending Catalyst

Analyst upgrade and $450 target rests on potential enterprise security spend surge linked to a forthcoming Anthropic model release

By Hana Yamamoto CRWD IGV
Wolfe Research Lifts CrowdStrike to Outperform Citing Anthropic AI as Spending Catalyst
CRWD IGV

Wolfe Research raised its rating on CrowdStrike to "outperform" from "peer perform," assigning a $450 price target that implies about 21.8% upside from the stock's $369.58 level. The brokerage pointed to an anticipated Anthropic model release as a potential trigger for faster enterprise security spending; the move came as shares reacted in pre-market trading and follows a recent pullback after leaked reports about the new Anthropic model.

Key Points

  • Wolfe Research upgraded CrowdStrike to "outperform" from "peer perform" and set a $450 price target, implying about 21.8% upside from a $369.58 price.
  • The brokerage views an anticipated Anthropic model release as a potential catalyst for accelerated enterprise security spending; the stock rose about 3% in pre-market trade after the upgrade.
  • Wolfe's upside model accelerates ARR growth to 25.5% in FY27, projects total revenue of $5.99B in FY27 and ARR of $6.59B in FY27, while forecasting product mix shifts such as a decline in Core Endpoint ARR share.

Wolfe Research upgraded CrowdStrike Holdings Inc. to "outperform" from "peer perform" on Monday and set a $450 price target, a level Wolfe says represents roughly 21.8% upside from the stock's $369.58 price. The firm cited a potential catalyst in the form of an expected Anthropic model release that could accelerate corporate security budgets. The announcement coincided with a roughly 3% rise in CrowdStrike shares during pre-market trading.

The upgrade follows a drop of about 6% in CRWD shares when news leaked that Anthropic planned to introduce a model named Mythos, which was reported to have materially stronger cybersecurity capabilities than earlier releases. Year-to-date, the stock is down 21%, compared with a 27% decline for the IGV ETF over the same period.

Wolfe analysts framed the outlook for security spending in stark terms, arguing that a deterioration in threat perception typically does not reduce defensive investment. As they put it:

"We don’t think anyone hears ’war is coming’ and chooses to spend less on guns and ammo," Wolfe analysts said, adding that their base case assumes minimal negative impact on security budgets over the next 12 months and that there is upside if enterprises move quickly to strengthen defenses.

On valuation, Wolfe's $450 target implies EV/CY27E revenue and free cash flow (FCF) multiples of 15.8x and 49x on the firm's base case estimates. Those multiples compare with CrowdStrike's three-year average FY+2 multiples of 15.5x on revenue and 50.5x on FCF. At the time of Wolfe's note, CRWD was trading at approximately 13x and 40x EV/CY27E revenue and FCF, respectively, which the brokerage noted sit below those historical averages.

Wolfe also published an upside case that accelerates several operating metrics. The brokerage forecasts annual recurring revenue (ARR) growth to accelerate by 1.7 percentage points to 25.5% in fiscal 2027, which Wolfe says is roughly two percentage points above the company's guidance of 23.6% year-over-year. In that upside scenario, net new ARR growth is modeled at 32% in FY27 versus management guidance of 22.5%, then easing to 12% in FY28 and 10% in FY29.

Wolfe's retention assumptions call for net revenue retention of 118% in FY27, a modest decline to 117% in FY28 and to 115% in FY29. Total revenue is estimated at $5.99 billion in FY27, $7.42 billion in FY28 and $9.04 billion in FY29. ARR is projected to reach $6.59 billion in FY27, $8.09 billion in FY28 and $9.74 billion in FY29.

The brokerage broke out growth across product lines in its model. It forecasts LogScale Next-Gen SIEM ARR to expand 62.3% in FY27, Identity ARR to grow 35.6% and Cloud Security ARR to rise 36.0%. Wolfe's modeling also shows a shift in product mix: Core Endpoint ARR, which accounted for 53.0% of total ARR in FY26, is projected to decline to 46.5% of total ARR in FY27.


Wolfe referenced primary research to support its stance. In the firm's 2026 CISO survey, CrowdStrike ranked first among vendors where respondents planned to spend the most absolute dollars and was also first in platform adoption intentions for 2026. In a separate RSA survey highlighted by the brokerage, 82% of respondents said they expected to increase spending on AI/ML security - the highest percentage of any spending segment - and that figure exceeded the second-ranked category by 22 percentage points.

The brokerage cautioned that the actual Anthropic model announcement, expected in early April, could act as a near-term negative catalyst on the day it is released. Wolfe also listed several key downside risks to its thesis, including the potential for AI model companies to encroach further into cybersecurity, the risk that emerging module growth slows materially in FY27, and the possibility of industry-wide discounting that could pressure growth.

Investors will therefore weigh the upgrade and the bullish scenarios Wolfe laid out against those execution and market risks as the anticipated Anthropic release approaches.

Risks

  • AI model companies could encroach further on cybersecurity - a risk that would primarily affect cybersecurity and enterprise software vendors.
  • Emerging module growth could slow materially in FY27 - a growth and execution risk for CrowdStrike and related security product lines.
  • Industry-wide discounting could pressure growth - a market-level risk that could impact revenue and margin dynamics across the cybersecurity sector.

More from Stock Markets

Nexstar Stock Drops After Judge Orders Halt to Tegna Transaction Mar 30, 2026 China Southern Posts 2025 Net Profit of 857 Million Yuan, Exits Five-Year Loss Streak Mar 30, 2026 HSBC Elevates Carnival to Buy, Cites Resilient Demand and Improving Financials Despite Fuel Pressure Mar 30, 2026 Insmed Shares Climb After UTHR TETON-1 Read-Through and Morgan Stanley Upgrade Mar 30, 2026 Volvo Cars Named Exclusive Importer for Lynk & Co in Europe Under New Commercial Pact Mar 30, 2026